CHI Gathers Biomedical Community for the California Healthcare Policy Forum
Event to Address Healthcare Reform’s Impact on Biomedical Innovation
SAN FRANCISCO--(BUSINESS WIRE)--CHI-California Healthcare Institute:
|
Who: |
CHI-California Healthcare Institute today will gather opinion leaders from the science, business and public sectors to discuss opportunities and issues facing the biomedical community for the 2009 California Healthcare Policy Forum. | |||
|
Political leaders addressing the forum include Attorney General Jerry Brown, California Insurance Commissioner Steve Poizner and Assemblymembers Nathan Fletcher and Jose Solorio. The forum will be moderated by futurist Ian Morrison, Ph.D., and CHI’s President and Chief Executive Officer, David L. Gollaher, Ph.D. The forum will gather academic leaders including Alan M. Garber, M.D., Ph.D., director, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, and A. Eugene Washington, M.D., M.Sc., executive vice chancellor and provost of University of California, San Francisco; and business leaders including Sharon Levine, M.D., associate executive medical director, The Permanente Medical Group; Mark D. Smith, M.D., M.B.A., president and CEO, California HealthCare Foundation; Michael Goldberg, partner, Mohr Davidow Ventures; Hans Bishop, president, specialty medicine, Bayer HealthCare LLC; Robert B. Hance, president, Abbott Vascular; Carl W. Hull, president and CEO, Gen-Probe Incorporated; Michael A. Mussallem, chairman and CEO, Edwards Lifesciences; and John C. Martin, Ph.D., chairman of the board and CEO, Gilead Sciences. |
||||
|
Where: |
InterContinental Mark Hopkins San Francisco Hotel, One Nob Hill, San Francisco, Calif. 94108 | |||
|
When: |
Thursday, Nov. 5, from 11:30 a.m. to 6:00 p.m. | |||
|
Why: |
The forum is designed to help attendees better understand healthcare reform and what it means to medical innovation in California, the birthplace of biotechnology. California’s biomedical community is made up of more than 2,000 biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations and employs more than 271,000 Californians. | |||
About CHI
CHI represents more than 250 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s Web site is www.chi.org.
Email
